Protalix BioTherapeutics Appoints Shmuel "Muli" Ben Zvi, Ph.D. to its Board of Directors
Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), announced today that the Company's Board of Directors has appointed Shmuel "Muli" Ben Zvi, Ph.D. to serve on the Company's Board of Directors...
Related Articles
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Former Aes Ceo Paul Hanrahan Elected to Arch Coal's Board of Directors also published in PR Newswire
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- Is Corporate America Really That Far Removed from the Days of Kozlowski? also mentions NYSE
- Why Do Board Directors And CEOs Need To Value UN Sustainability Goal 5 ? - Achieve Gender Equality And Empower All Women And Girls also categorized in BoardMoves
- New Slate of Directors to be Proposed for Cathay Forest Products Corp. also published in PR Newswire
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- D.C. United’s Danita Johnson Becomes First Woman To Join Buzzer’s Board Of Directors also categorized in BoardMoves
- Astoria Financial Corporation Announces The Resignation Of Chairman George L. Engelke, Jr. And The Appointment Of ... also published in PR Newswire
Login to comment.